Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06399510

Electrolyte Balance Effects of Sterofundin Versus Normal Saline in Diabetic Ketoacidosis

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
58 (estimated)
Sponsor
Universiti Sains Malaysia · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The goal of this prospective single centered randomized control trial is to compare the electrolyte balance effects between Sterofundin and Normal Saline in Diabetic Ketoacidosis patients. The main questions it aims to answer are: i. Is there any difference in duration of bicarbonate (HCO3-) to reach equal or more than 15mmol/L from the initial blood taking in between Sterofundin and NS fluid use in DKA patients? ii. Is there any difference in the level of post-infusion serum sodium (Na+) between Sterofundin and NS fluid use in DKA patients? iii. Is there any difference in the level of post-infusion serum potassium (K+) between Sterofundin and NS fluid use in DKA patients? Patients will be randomized in a 1:1 ratio to receive IV Sterofundin (intervention) or IV Normal Saline (standard care). The patient will have the respective fluid regime as the main fluid therapy during the first 24 hours of ICU stay. If patients were randomized to the control arm, the fluid regime for the first 24 hours in ICU will be normal saline. If patients were randomized to the interventional arm, the main fluid therapy during the first 24 hours of ICU stay will be Sterofundin.

Conditions

Interventions

TypeNameDescription
OTHERSterofundin fluid therapySterofundin is known as balanced solution which has similar electrolytes content as per human plasma.

Timeline

Start date
2024-03-01
Primary completion
2025-03-31
Completion
2025-04-30
First posted
2024-05-03
Last updated
2024-05-03

Locations

1 site across 1 country: Malaysia

Source: ClinicalTrials.gov record NCT06399510. Inclusion in this directory is not an endorsement.

Electrolyte Balance Effects of Sterofundin Versus Normal Saline in Diabetic Ketoacidosis (NCT06399510) · Clinical Trials Directory